Company intelligence / Profile preview

Codon Devices

Cambridge, Massachusetts, United Statescodondevices.com ↗

Ownership: Private
Development stage: Commercial

Overview

Codon Devices developed proprietary synthetic biology platforms to enable rapid and cost-effective gene synthesis. The company did not report clinical results as it focused on providing research tools and services. It ceased operations in 2009 due to financial difficulties.

Modalities: Engineered gene librariesEngineered cellsDNA synthesis
Industry: Non-Drug Biotech

Partnerships

U.S. Commerce Department’s National Institute of Standards and Technology (NIST) grant recipient for microfluidics platform development

Beyond the preview

Go deeper on Codon Devices.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Codon Devices.

Explore the full profile